MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Oversubscribed: Venture & Risk Capital Round_$100m+
Convergence Pharmaceuticals, Ltd
Parents
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars)
Oversubscribed: Venture & Risk Capital Round_$100m+
Children
Closed a $35.4M Series A financing.
Convergence Pharmaceuticals (United Kingdom) a clinical-stage small molecule company focused on the treatment of neuropathic and chronic pain
Convergence Pharmaceuticals, Ltd.: Series A $35.4M
Participants include New Leaf Venture Partners, Apposite Capital and SV Life Sciences.